Table 4.

Known groups validity of the UCT (CSU and CINDU).

	N	Mean	SD	Median	Kruskal-Vallis Test	p
PatGA-LS-1st CSU
No complaints	16	15.13	2.062	16.00	47.178	<0.001
Mild complaints	34	11.09	2.690	12.00
Moderate complaints	25	8.04	2.336	8.00
Severe complaints	6	4.33	3.204	3.50
PatGA-LS-1st CINDU
No complaints	3	13.67	1.155	13.00	34.226	<0.001
Mild complaints	20	11.25	2.826	12.00
Moderate complaints	40	7.80	2.662	8.00
Severe complaints	15	5.27	2.086	6.00
PHYGA-LS-1st CSU
Complete control	19	14.16	2.651	15.00	43.629	<0.001
Good control	34	11.24	2.742	12.00
Moderate control	23	7.65	2.367	7.00
Little control	2	7.00	1.414	7.00
No control	3	1.67	0.577	2.00
PHY-LS-1st CINDU
Complete control	1	16.00		16.00	49.100	<0.001
Good control	18	12.78	1.396	12.50
Moderate control	36	7.89	1.997	8.00
Little control	20	5.85	2.277	6
No control	3	3.33	2.082	4
UAS28-1st-R
<6	14	14.79	2.517	16.00	34.281	0.000
7-24	23	11.39	3.394	12.00
25-64	19	9.63	3.804	10.00
>65	25	7.76	2.454	8.00
PAT-ATR-1st CSU
Treatment sufficient	53	12.19	3.051	12.00	196.000	0.000
Treatment not sufficient	28	7.14	3.147	7.00
PAT-ATR-1st CINDU
Treatment not sufficient	49	6.53	2.399	6.00	87.500	0.000
Treatment sufficient	29	11.62	2.321	12.00
PHY-ATR-1st CSU
Treatment sufficient	52	12.31	3.052	12.00	170.000	0.000
Treatment not sufficient	29	7.10	2.920	7.00
PHY-ATR-1st CINDU
Treatment not sufficient	59	6.92	2.336	7.00	49.555	0.000
Treatment sufficient	19	13.11	1.329	13.00

Kruskal-Vallis.